
AstraZeneca’s Lokelma has been approved by the National Medical Products Administration in China. This is due to positive results based …

Researchers from the Joslin Diabetes Center (JDC) have developed a prognostic tool which they claim can accurately predict the risk …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

